Grazax
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background: Allergic rhinitis is a major chronic respiratory disease that affects between 10% and 30% of adults and up to 40% of…
SUMMARY Sub-lingual immunotherapy (SLIT) for the treatment of various allergies is well established as exemplified by Grastek…
SUMMARY The ZYDIS orally disintegrating tablet has been optimized to produce a stable, freeze dried, dose form for the sub…
From the Section of Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College and Royal Brompton…
Over 1 in 5 adults in the UK are estimated to have allergic rhinitis and around half of these people are allergic to grass pollen…
Grazax is a self-administered, once-daily, tablet-based vaccine that offers an alternative to allergy shots for adults with grass…